Cargando…

The Japan Statin Treatment Against Recurrent Stroke (J-STARS) Trial: Where to Now?

Detalles Bibliográficos
Autor principal:	Hankey, Graeme J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4588442/ https://www.ncbi.nlm.nih.gov/pubmed/26501089 http://dx.doi.org/10.1016/j.ebiom.2015.08.007

Ejemplares similares

Rationale, design, and baseline features of a randomized controlled trial to assess the effects of statin for the secondary prevention of stroke: the Japan Statin Treatment Against Recurrent Stroke (J-STARS)
por: Nagai, Yoji, et al.
Publicado: (2014)

The Japan Statin Treatment Against Recurrent Stroke (J-STARS): A Multicenter, Randomized, Open-label, Parallel-group Study
por: Hosomi, Naohisa, et al.
Publicado: (2015)

Long-Term Effect of Pravastatin on Carotid Intima–Media Complex Thickness: The J-STARS Echo Study (Japan Statin Treatment Against Recurrent Stroke)
por: Koga, Masatoshi, et al.
Publicado: (2018)

Social radiology: Where to now?
por: Ho, ELM
Publicado: (2012)

Neoadjuvant treatment of rectal cancer: where are we now?
por: Kalyan, Aparna, et al.
Publicado: (2016)

AI in medicine: Where are we now and where are we going?
por: Shandhi, Md Mobashir Hasan, et al.
Publicado: (2022)

Ventilator-associated tracheobronchitis: where are we now?
por: Nseir, Saad, et al.
Publicado: (2014)

Genetic counseling globally: Where are we now?
por: Ormond, Kelly E., et al.
Publicado: (2018)

COVID-19 – Where should we go now?
por: Allen, Claire, et al.
Publicado: (2020)

Effect of Statin on Stroke Recurrence Prevention at Different Infarction Locations: A Post Hoc Analysis of The J-STARS Study
por: Nezu, Tomohisa, et al.
Publicado: (2020)

Anti-cytokine therapy in fibrosing alveolitis: where are we now?
por: Millar, Ann
Publicado: (2000)

Medically Complex Living Kidney Donors: Where Are We Now?
por: Textor, Stephen C.
Publicado: (2019)

Polygenic risk scores for complex diseases: where are we now?
por: Loh, Marie, et al.
Publicado: (2023)

Conduction System Pacing: Where Are We Now?
por: Niazi, Imran
Publicado: (2022)

Mobile Phones, Brain Tumors, and the Interphone Study: Where Are We Now?
por: Swerdlow, Anthony J., et al.
Publicado: (2011)

Mechanical Thrombectomy- Where Do We Stand Now ?
por: Chakraborty, Debabrata, et al.
Publicado: (2022)

Different Influences of Statin Treatment in Preventing At-Risk Stroke Subtypes: A Post Hoc Analysis of J-STARS
por: Hosomi, Naohisa, et al.
Publicado: (2020)

Where are we now with aphasia after Stroke?
por: Enderby, Pam, et al.
Publicado: (2020)

Antibodies against recombinant enzyme in the treatment of Fabry disease: Now you see them, now you don’t
por: van der Veen, Sanne Jolien, et al.
Publicado: (2022)

5-α reductase inhibitors and prostate cancer prevention: where do we turn now?
por: Hamilton, Robert J, et al.
Publicado: (2011)

Extension for Community Healthcare Outcomes (ECHO) Telementoring in the Military: Where We Are Now, Opportunities and Challenges
por: Katzman, Joanna, et al.
Publicado: (2021)

World Health Organization AWaRe framework for antibiotic stewardship: Where are we now and where do we need to go? An expert viewpoint
por: Mudenda, Steward, et al.
Publicado: (2023)

Stroke Prevention in Atrial Fibrillation: Where are We Now?
por: Ahmad, Yousif, et al.
Publicado: (2012)

Vaccines against Tuberculosis: Where Are We Now?
por: Srivastava, Shruti, et al.
Publicado: (2023)

Where are we now?
Publicado: (1977)

Voices: Where are they now?
Publicado: (2023)

Every Minute Counts—The Time Is Now to Understand Predictors of Stroke in HIV
por: Srinivasa, Suman, et al.
Publicado: (2019)

Reduction in High-Sensitivity C-Reactive Protein Levels in Patients with Ischemic Stroke by Statin Treatment: Hs-CRP Sub-Study in J-STARS
por: Kitagawa, Kazuo, et al.
Publicado: (2017)

The OSCILLATE trial: Implications for respiratory therapists then and now
por: Hand, Lori
Publicado: (2014)

Optimizing twice weekly dialysis-converting two-star into five-star treatment?
por: Kher, A., et al.
Publicado: (2015)

Where are we now and where are we headed?
por: Langan, Ewan A.
Publicado: (2023)

Treatment of uveal melanoma: where are we now?
por: Yang, Jessica, et al.
Publicado: (2018)

Hepatitis C treatment: where are we now?
por: Burstow, Nicholas J, et al.
Publicado: (2017)

Stroke and Bleeding Risk Assessment in Atrial Fibrillation: Where Are We Now?
por: Kuo, Ling, et al.
Publicado: (2021)

Birth then and now
por: Lumley, Judith
Publicado: (2008)

Bisphenol A: Where to Now?
por: Bucher, John R.
Publicado: (2009)

NIPPV: Where Are We Now?
por: Fakharian, Atefeh, et al.
Publicado: (2013)

Onchodermatitis: Where Are We Now?
por: Murdoch, Michele E.
Publicado: (2018)

A regulatory challenge for natural language processing (NLP)‐based tools such as ChatGPT to be legally used for healthcare decisions. Where are we now?
por: Baumgartner, Christian, et al.
Publicado: (2023)

Where is Archives of Plastic Surgery Now? And Where is It Heading?
por: Kim, Jeong Tae
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_gp7ebg2nhemah7if3n29evomdi